School of medicine

School Notes: School of Medicine
March/April 2016

Robert J. Alpern | http://medicine.yale.edu

New leadership at Child Study Center

Linda C. Mayes, the Arnold Gesell Professor of Child Psychiatry, Pediatrics, and Psychology in the Yale Child Study Center (CSC), has been appointed chair of the CSC and chief of the Department of Child Psychiatry at Yale–New Haven Hospital. Her research integrates perspectives from child development, behavioral neuroscience, psychophysiology and neurobiology, developmental psychopathology, and neurobehavioral teratology. She has published widely in the developmental psychology, pediatrics, and child psychiatry literature. Her work focuses on stress-response and regulatory mechanisms in young children at both biological and psychosocial risk, with special attention to addictive behaviors and processes within a neurodevelopmental framework and using multi-modal imaging methods.

Mayes joined the Yale faculty in 1985. She succeeds Fred Volkmar, Irving B. Harris Professor in the CSC, who became director of the center in July 2006 and continued the center’s tradition as a national and international leader in the field of children’s mental health.

Yale oncologist on cancer panel

Patricia M. LoRusso, professor of medicine and associate director of innovative medicine at Yale Cancer Center, was among a group of 15 top cancer researchers and clinician-scientists who met in Washington January 8 with aides to Vice President Joseph Biden, to discuss his “moonshot” program to advance cancer treatment. The panel, convened by the American Association for Cancer Research, met with the vice president’s staff prior to the president’s announcement of a national effort to find innovative treatments for cancer, in which he designated Biden, who lost an adult son to cancer last year, as “mission control.” Among the goals of the program, called Cancer MoonShot 2020, are to increase funding for cancer research, to facilitate interdisciplinary collaboration, and to support research into cutting-edge treatments like immunotherapy combination therapy, early detection techniques, and vaccines. LoRusso has garnered an international reputation as a leader in medical oncology, drug development, and early-phase clinical trials. She joined the School of Medicine faculty in 2014.

The comment period has expired.